Skip to main content

Articles

Page 4 of 61

  1. Cardiovascular diseases (CVDs) remain a major global health concern, necessitating advanced risk assessment beyond traditional factors. Early vascular aging (EVA), characterized by accelerated vascular changes...

    Authors: Iván Cavero-Redondo, Alicia Saz-Lara, Irene Martínez-García, Iris Otero-Luis and Arturo Martínez-Rodrigo
    Citation: Cardiovascular Diabetology 2024 23:33
  2. Sarcopenia is frequently found in patients with heart failure with reduced ejection fraction (HFrEF) and is associated with reduced exercise capacity, poor quality of life and adverse outcomes. Recent evidence...

    Authors: Ke Shi, Ge Zhang, Hang Fu, Xue-Ming Li, Shi-Qin Yu, Rui Shi, Wei-Feng Yan, Wen-Lei Qian, Hua-Yan Xu, Yuan Li, Ying-Kun Guo and Zhi-Gang Yang
    Citation: Cardiovascular Diabetology 2024 23:28
  3. The triglyceride-glucose (TyG) index, identified as a reliable indicator of insulin resistance (IR), was reported to be associated with stroke recurrence and morbidity in the general population and critically ...

    Authors: Zhendong Ding, Mian Ge, Yuexiang Tan, Chaojin Chen and Ziqing Hei
    Citation: Cardiovascular Diabetology 2024 23:27
  4. To investigate the correlation between triglyceride glucose index (TyG) and collateral circulation in patients with chronic total occlusion (CTO) of coronary arteries in different glucose metabolic states.

    Authors: Junwei Zhu, Minghui Niu, Chenxing Wang, Ying Liang, Rong Guo and Fei He
    Citation: Cardiovascular Diabetology 2024 23:26
  5. Studies have shown that insulin resistance is strongly associated with the development of cardiovascular disease, and the triglyceride glucose-body mass index (TyG-BMI index) is considered to be a reliable sur...

    Authors: Xueyuan Yang, Kui Li, Jiaojiao Wen, Changlong Yang, Yunhang Li, Guanxue Xu and Yi Ma
    Citation: Cardiovascular Diabetology 2024 23:24
  6. The TyG index, a prominent metric for assessing insulin resistance, has gained traction as a prognostic tool for cardiovascular disease. Nevertheless, the understanding of the prognostic significance of the ex...

    Authors: Zhengwen Xu, Peixian Chen, Lian Wang, Jie Yan, Xisheng Yan and Dongsheng Li
    Citation: Cardiovascular Diabetology 2024 23:23
  7. Myocardial infarction (MI), stroke, peripheral arterial disease (PAD), heart failure (HF) and chronic kidney disease (CKD) are common cardiovascular renal diseases (CVRD) manifestations for type 2 diabetes. Th...

    Authors: Patrick Blin, Michael Joubert, Patrick Jourdain, Philippe Zaoui, Estelle Guiard, Dunia Sakr, Caroline Dureau-Pournin, Marie-Agnès Bernard, Régis Lassalle, Florence Thomas-Delecourt, Sébastien Bineau, Nicholas Moore and Cécile Droz-Perroteau
    Citation: Cardiovascular Diabetology 2024 23:22
  8. Atherosclerosis is one of the leading causes of death worldwide. miR-26 is a potential biomarker of atherosclerosis. Standardized diagnostic tests for miR-26 (MIR26-DX) have been developed, but the fastest pro...

    Authors: Wujun Chen, Xiaolin Wu, Jianxia Hu, Xiaolei Liu, Zhu Guo, Jianfeng Wu, Yingchun Shao, Minglu Hao, Shuangshuang Zhang, Weichao Hu, Yanhong Wang, Miao Zhang, Meng Zhu, Chao Wang, Yudong Wu, Jie Wang…
    Citation: Cardiovascular Diabetology 2024 23:21
  9. Remnant cholesterol (RC) is implicated in the risk of cardiovascular disease. However, comprehensive population-based studies elucidating its association with aortic valve calcium (AVC) progression are limited...

    Authors: Ze-Hua Li, Qing-Yun Hao, Yu-Hong Zeng, Jing-Bin Guo, Shi-Chao Li, Jing-Wei Gao and Ping-Zhen Yang
    Citation: Cardiovascular Diabetology 2024 23:20
  10. Diabetic cardiomyopathy (DCM) is a major cause of mortality in patients with diabetes, and the potential strategies for treating DCM are insufficient. Melatonin (Mel) has been shown to attenuate DCM, however, ...

    Authors: Shengzheng Zhang, Wencong Tian, Xianxian Duan, Qian Zhang, Lei Cao, Chunlei Liu, Guangru Li, Ziwei Wang, Junwei Zhang, Jing Li, Liang Yang, Yang Gao, Yang Xu, Jie Liu, Jie Yan, Jianlin Cui…
    Citation: Cardiovascular Diabetology 2024 23:19
  11. Increased risk of severe tachyarrhythmias is reported in patients with type 2 diabetes mellitus (T2DM). The aim of this study was to explore if treatment with cardiac implantable electronic device (CIED) such ...

    Authors: Elina Rautio, Fredrik Gadler, Soffia Gudbjörnsdottir, Stefan Franzén, Lars Rydén, Gianluigi Savarese, Ann-Marie Svensson and Linda G. Mellbin
    Citation: Cardiovascular Diabetology 2024 23:18
  12. Atherosclerosis is closely linked with glucose metabolism. We aimed to investigate the role of the atherogenic index of plasma (AIP) in the reversal of prediabetes to normal blood glucose levels or its progres...

    Authors: Hongyi Yang, Maobin Kuang, Ruijuan Yang, Guobo Xie, Guotai Sheng and Yang Zou
    Citation: Cardiovascular Diabetology 2024 23:17
  13. Findings from earlier research have established that insulin resistance (IR) is implicated in atherosclerosis progression, representing a noteworthy risk factor for cardiovascular disease (CVD). Recently, the ...

    Authors: Fadong Li, Yue Wang, Boqun Shi, Shuaifeng Sun, Shen Wang, Shuo Pang and Xiaofan Wu
    Citation: Cardiovascular Diabetology 2024 23:16
  14. Insulin resistance (IR), a hallmark of proceeding diabetes and cardiovascular (CV) disease, has been shown to predict prognosis in patients undergoing percutaneous coronary intervention (PCI). The triglyceride...

    Authors: Jining He, Chenxi Song, Sheng Yuan, Xiaohui Bian, Zhangyu Lin, Min Yang and Kefei Dou
    Citation: Cardiovascular Diabetology 2024 23:15
  15. To delineate the metabolomic differences in plasma samples between patients with coronary artery disease (CAD) and those with concomitant CAD and type 2 diabetes mellitus (T2DM), and to pinpoint distinctive me...

    Authors: Yingjian Liu, Ju-e Liu, Huafeng He, Min Qin, Heping Lei, Jinxiu Meng, Chen Liu, Xiaoping Chen, Wenwei Luo and Shilong Zhong
    Citation: Cardiovascular Diabetology 2024 23:14
  16. Metabolic effects of empagliflozin treatment include lowered glucose and insulin concentrations, elevated free fatty acids and ketone bodies and have been suggested to contribute to the cardiovascular benefits...

    Authors: Roopameera Thirumathyam, Erik Arne Richter, Gerrit van Hall, Jens Juul Holst, Mogens Fenger, Jens P. Gøtze, Ulrik Dixen, Niels Vejlstrup, Sten Madsbad, Per Lav Madsen and Nils Bruun Jørgensen
    Citation: Cardiovascular Diabetology 2024 23:13
  17. Abnormal lipid metabolism poses a risk for prediabetes. However, research on lipid parameters used to predict the risk of prediabetes is scarce, and the significance of traditional and untraditional lipid para...

    Authors: Mingkang Li, Wenkang Zhang, Minhao Zhang, Linqing Li, Dong Wang, Gaoliang Yan, Yong Qiao and Chengchun Tang
    Citation: Cardiovascular Diabetology 2024 23:12
  18. The role of triglyceride-glucose (TyG) index, an insulin resistance indicator, in glycemic management for diabetic patients with coronary artery disease (CAD) was still unknown. Therefore, we aimed to explore ...

    Authors: Zhangyu Lin, Jining He, Sheng Yuan, Chenxi Song, Xiaohui Bian, Min Yang and Kefei Dou
    Citation: Cardiovascular Diabetology 2024 23:11
  19. Few studies explored the effect of the combination of glucose sodium-cotransporter-2 inhibitors (SGLT-2i) and glucagon-like peptide-1 receptor agonists (GLP-1RA) on the incidence of cardiovascular events in pa...

    Authors: Raffaele Marfella, Francesco Prattichizzo, Celestino Sardu, Pier Francesco Rambaldi, Carlo Fumagalli, Ludovica Vittoria Marfella, Rosalba La Grotta, Chiara Frigé, Valeria Pellegrini, Davide D’Andrea, Arturo Cesaro, Paolo Calabrò, Carmine Pizzi, Roberto Antonicelli, Antonio Ceriello, Ciro Mauro…
    Citation: Cardiovascular Diabetology 2024 23:10
  20. Microvascular pathology is one of the main characteristics of diabetic cardiomyopathy; however, the early longitudinal course of diabetic microvascular dysfunction remains uncertain. This study aimed to invest...

    Authors: Li Jiang, Wei‑Feng Yan, Lu Zhang, Hua‑Yan Xu, Ying‑Kun Guo, Zhen-Lin Li, Ke-Ling Liu, Ling-Ming Zeng, Yuan Li and Zhi-Gang Yang
    Citation: Cardiovascular Diabetology 2024 23:9
  21. In the American population, the relationship between the triglyceride-glucose (TyG) index and TYG combined with indicators of obesity and cardiovascular disease (CVD) and its mortality has been less well studied.

    Authors: Keke Dang, Xuanyang Wang, Jinxia Hu, Yuntao Zhang, Licheng Cheng, Xiang Qi, Lin Liu, Zhu Ming, Xinmiao Tao and Ying Li
    Citation: Cardiovascular Diabetology 2024 23:8
  22. The triglyceride-glucose (TyG) index is a reliable surrogate marker of insulin resistance and previous studies have confirmed the association of TyG index with incident chronic kidney disease (CKD). However, t...

    Authors: Ning Chen, Lin-Lin Ma, Yu Zhang, Xi Chu, Jing Dong and Yu-Xiang Yan
    Citation: Cardiovascular Diabetology 2024 23:7
  23. The triglyceride-glucose (TyG) index is regarded as a sophisticated surrogate biomarker for insulin resistance, offering a refined means for evaluating cardiovascular diseases (CVDs). However, prospective coho...

    Authors: Yue Wang, Xueyu Chen, Jie Shi, Mingyi Du, Shengnan Li, Jinhong Pang, Junpeng Qiao, Yingying Zhao, Qiaoqiao Chen, Yuanyuan Guo, Yan Xi and Weiwei Chi
    Citation: Cardiovascular Diabetology 2024 23:6
  24. It is unknown whether high hemoglobin A1c (HbA1c) is associated with increases in the risk of cardiovascular disease among individuals with elevated genetic susceptibility. We aimed to investigate the associat...

    Authors: Juntae Kim, Dongmin Kim, Han-Joon Bae, Byoung-Eun Park, Tae Soo Kang, Seong-Hoon Lim, Su Yeon Lee, Young Hak Chung, Ji Wung Ryu, Myung-Yong Lee, Pil-Sung Yang and Boyoung Joung
    Citation: Cardiovascular Diabetology 2024 23:5
  25. The diabetogenic effect of statins has been well established by clinical trials, Mendelian randomisation studies and meta-analyses. According to large clinical trials, PCSK9 inhibitors (PCSK9i) have no deleter...

    Authors: Ana M. González-Lleó, Rosa M. Sánchez-Hernández, Núria Plana, Daiana Ibarretxe, Pere Rehues, Josep Ribalta, Dídac Llop, Ana M. Wägner, Lluís Masana and Mauro Boronat
    Citation: Cardiovascular Diabetology 2024 23:4
  26. The triglyceride-glucose (TyG) index has been proposed as a surrogate marker of insulin resistance. However, the relationship between the TyG index and central blood pressure (BP), has not been well studied in...

    Authors: Yin-Hua Sun, Nai-Qing Hu, Xian-Yi Huang, Zheng-Xin Liu, Qi-Yan Li, Qing-Lu Li and Li-Hua Li
    Citation: Cardiovascular Diabetology 2024 23:3
  27. Numerous clinical studies have explored sodium–glucose cotransporter 2 inhibitor (SGLT2i) in patients with chronic heart failure (CHF), with or without type 2 diabetes mellitus (T2DM), and SGLT2i were proved t...

    Authors: Jiao Chen, Chunxia Jiang, Man Guo, Yan Zeng, Zongzhe Jiang, Dongmin Zhang, Mengqin Tu, Xiaozhen Tan, Pijun Yan, XunMei Xu, Yang Long and Yong Xu
    Citation: Cardiovascular Diabetology 2024 23:2
  28. Obesity has increased in recent years with consequences on diabetes and other comorbidities. Thus, 1 out of 3 diabetic patients suffers cardiovascular disease (CVD). The network among glucose, immune system, e...

    Authors: David García-Vega, David Sánchez-López, Gemma Rodríguez-Carnero, Rocío Villar-Taibo, Juan E. Viñuela, Adán Lestegás-Soto, Ana Seoane-Blanco, María Moure-González, Susana B. Bravo, Ángel L. Fernández, José R. González-Juanatey and Sonia Eiras
    Citation: Cardiovascular Diabetology 2024 23:1
  29. This study aimed to investigate the risks of all-cause and cardiovascular mortality associated with blood pressure (BP) levels of 130–139/80–89 mmHg in Chinese adults with different glucose metabolism, during ...

    Authors: Chang-Sheng Sheng, Haiyan Wang, Yanjun Liu, Yanyun Li, TianZhiChao Hou, Miaoyan Qiu, Yao Lu, Siming Sun, Junhan Yang, Xiaomin Song, Guang Ning and Jingyan Tian
    Citation: Cardiovascular Diabetology 2023 22:353
  30. Primary aldosteronism (PA) is an adrenal disorder of autonomous aldosterone secretion which promotes arterial injury. We aimed to explore whether PA is causally associated with lower-extremity arterial disease...

    Authors: Jinbo Hu, Qinglian Zeng, Xiangjun Chen, Wenjin Luo, Ziwei Tang, Mei Mei, Wenrui Zhao, Zhipeng Du, Zhiping Liu, Qifu Li, Qingfeng Cheng and Shumin Yang
    Citation: Cardiovascular Diabetology 2023 22:352
  31. Adiposity and elevated inflammation are two hallmarks of hyperglycemia. However, it is unknown whether clustering of elevated inflammation and adiposity interact act on diabetogenesis and lead to a greater ris...

    Authors: Dan Wu, Yulong Lan, Shuohua Chen, Xiong Ding, Guanzhi Chen, Chutao Wu, Lois Balmer, Wencan Xu, Shouling Wu and Wei Wang
    Citation: Cardiovascular Diabetology 2023 22:351
  32. Elevated glycated hemoglobin (HbA1c) is associated with a higher burden of subclinical atherosclerosis (SA). However, the association with SA of earlier insulin resistance markers is poorly understood. The stu...

    Authors: Josep Iglesies-Grau, Ana Garcia-Alvarez, Belén Oliva, Guiomar Mendieta, Inés García-Lunar, José J. Fuster, Ana Devesa, Cristina Pérez-Herreras, Antonio Fernández-Ortiz, Ramon Brugada, Borja Ibanez, Rodrigo Fernandez-Jimenez and Valentin Fuster
    Citation: Cardiovascular Diabetology 2023 22:350
  33. We recently demonstrated that treatment with sodium-glucose cotransporter-2 inhibitors (SGLT-2i) leads to an increase in myocardial flow reserve in patients with type 2 diabetes (T2D) with stable coronary arte...

    Authors: Francesca Cinti, Lucia Leccisotti, Gian Pio Sorice, Umberto Capece, Domenico D’Amario, Margherita Lorusso, Shawn Gugliandolo, Cassandra Morciano, Andrea Guarneri, Maria Angela Guzzardi, Teresa Mezza, Amedeo Capotosti, Luca Indovina, Pietro Manuel Ferraro, Patricia Iozzo, Filippo Crea…
    Citation: Cardiovascular Diabetology 2023 22:349
  34. Prediabetes, an intermediate stage between normal blood sugar levels and a diabetes mellitus diagnosis, is increasing in prevalence. Severe prediabetes is associated with a similar risk of complications as dia...

    Authors: Jung-Chi Hsu, Yen-Yun Yang, Shu-Lin Chuang, Jen-Kuang Lee and Lian-Yu Lin
    Citation: Cardiovascular Diabetology 2023 22:348
  35. Previous studies have found that the triglyceride glucose index (TyG index) trajectories are associated with cardiovascular diseases. However, the association between the patterns of TyG index trajectories and...

    Authors: Fengling Xin, Shuyou He, Yu Zhou, Xueni Jia, Yulong Zhao and Hui Zhao
    Citation: Cardiovascular Diabetology 2023 22:347
  36. This study aimed to evaluate the association of triglyceride-glucose (TyG) index, an insulin resistance surrogate biomarker, with first stroke in a hypertensive population and to explore potential influencing ...

    Authors: Nan Zhang, Xiying Chi, Ziyi Zhou, Yun Song, Shuqun Li, Jiafeng Xu and Jianping Li
    Citation: Cardiovascular Diabetology 2023 22:346
  37. The association between obesity indicators and mortality in individuals with diabetes remains unclear, and data on cardiovascular mortality are scarce. Therefore, we investigated the associations between the f...

    Authors: Chung-Yen Lu, Hsiao-Hui Chen, Kuan-Hui Chi and Pei-Chun Chen
    Citation: Cardiovascular Diabetology 2023 22:345
  38. In the last years, the classical pattern of diabetic kidney disease (DKD) has been partially overcome, because of the uncovering of a new DKD phenotype with significant renal dysfunction without presence of al...

    Authors: Maurizio Di Marco, Sabrina Scilletta, Nicoletta Miano, Nicola Marrano, Annalisa Natalicchio, Francesco Giorgino, Stefania Di Mauro, Agnese Filippello, Alessandra Scamporrino, Paola Tribulato, Giosiana Bosco, Francesco Di Giacomo Barbagallo, Roberto Scicali, Agostino Milluzzo, Teresa Ballirò, Lucia Frittitta…
    Citation: Cardiovascular Diabetology 2023 22:344
  39. Prior studies suggest a link between metabolic dysfunction-associated steatotic liver disease (MASLD) and incident arrhythmias, including atrial fibrillation (AF). However, robust data are lacking from cohorts...

    Authors: Tracey G. Simon, Fahim Ebrahimi, Bjorn Roelstraete, Hannes Hagström, Johan Sundström and Jonas F. Ludvigsson
    Citation: Cardiovascular Diabetology 2023 22:343
  40. Data are limited on the association of metabolic dysfunction-associated fatty liver disease (MAFLD) with systemic atherosclerosis. This study aimed to examine the relationship between MAFLD and the extent of a...

    Authors: Yanli Zhang, Zhang Xia, Xueli Cai, Xin Su, Aoming Jin, Lerong Mei, Jing Jing, Suying Wang, Xia Meng, Shan Li, Mengxing Wang, Tiemin Wei, Yongjun Wang, Yan He and Yuesong Pan
    Citation: Cardiovascular Diabetology 2023 22:342
  41. Previous studies using trajectory models focused on examining the longitudinal changes in triglyceride-glucose (TyG) levels and lifestyle scores separately, without exploring the joint evolution of these two f...

    Authors: Hui Zhou, Xiong Ding, Yulong Lan, Shuohua Chen, Shouling Wu and Dan Wu
    Citation: Cardiovascular Diabetology 2023 22:341
  42. Olive oil consumption has been inversely associated with the risk of type 2 diabetes (T2D) and cardiovascular disease (CVD). However, the impact of olive oil consumption on plasma metabolites remains poorly un...

    Authors: Jesús F. García-Gavilán, Nancy Babio, Estefanía Toledo, Zhila Semnani-Azad, Cristina Razquin, Courtney Dennis, Amy Deik, Dolores Corella, Ramón Estruch, Emilio Ros, Montserrat Fitó, Fernando Arós, Miquel Fiol, José Lapetra, Rosa Lamuela-Raventos, Clary Clish…
    Citation: Cardiovascular Diabetology 2023 22:340
  43. The risk of cardiovascular disease (CVD) depended on the magnitude and exposure duration of insulin resistance (IR). This study aimed to investigate the associations of cumulative metabolic score for IR (cumME...

    Authors: Xue Tian, Shuohua Chen, Qin Xu, Xue Xia, Yijun Zhang, Penglian Wang, Shouling Wu and Anxin Wang
    Citation: Cardiovascular Diabetology 2023 22:339
  44. Previous observational studies have documented an inverse association of birthweight with myocardial infarction (MI) but a positive association with atrial fibrillation (AF). However, the causality of these as...

    Authors: Lijie Kong, Yiying Wang, Chaojie Ye, Chun Dou, Dong Liu, Min Xu, Jie Zheng, Ruizhi Zheng, Yu Xu, Mian Li, Zhiyun Zhao, Jieli Lu, Yuhong Chen, Weiqing Wang, Ruixin Liu, Yufang Bi…
    Citation: Cardiovascular Diabetology 2023 22:338
  45. Subjects with type 2 diabetes (T2D) have a higher risk of in-stent restenosis and stent thrombosis. The activation of the glucagon-like peptide-1 receptor (GLP-1R) has been suggested to induce several effects ...

    Authors: Irene Santos-Pardo, Nils Witt, Oskar Angerås and Thomas Nyström
    Citation: Cardiovascular Diabetology 2023 22:337
  46. The effects of diabetes on the cardiac and aortic structure and function remain unclear. Detecting and intervening these variations early is crucial for the prevention and management of complications. Cardiova...

    Authors: Zhaoyue Li, Jie Xiong, Yutong Guo, Hao Tang, Bingchen Guo, Bo Wang, Dianyu Gao, Zengxiang Dong and Yingfeng Tu
    Citation: Cardiovascular Diabetology 2023 22:336
  47. The assessment of obesity-related health risks has traditionally relied on the Body Mass Index and waist circumference, but their limitations have propelled the need for a more comprehensive approach. The diff...

    Authors: Marta Lopez-Yus, Carmen Casamayor, Juan Jose Soriano-Godes, Sofia Borlan, Yolanda Gonzalez-Irazabal, Maria Pilar Garcia-Sobreviela, Beatriz Garcia-Rodriguez, Raquel del Moral-Bergos, Pilar Calmarza, Jose Maria Artigas, Silvia Lorente-Cebrian, Vanesa Bernal-Monterde, Alejandro Sanz-Paris and Jose M. Arbones-Mainar
    Citation: Cardiovascular Diabetology 2023 22:335
  48. Stress hyperglycemia ratio (SHR), associated with adverse outcomes in patients with ST-segment elevation myocardial infarction (STEMI), has several definitions. This study aims to assess the prognostic value o...

    Authors: Wang Liao, Yuwen Chen, Qiyue Gao, Rongrong Gan, Ming Li, Zhenliang Liu, Jiasheng Liang, Henghua Cui, Kaida Ren, Yabin Liu, Zhengdong Wang, Jun Jiang and Qucheng Wei
    Citation: Cardiovascular Diabetology 2023 22:334
  49. Insulin resistance is a pivotal risk factor for cardiovascular diseases, and the triglyceride-glucose (TyG) index is a well-established surrogate of insulin resistance. This study aimed to investigate the prog...

    Authors: Yu Zhang, Ce Zhang, Lin Jiang, Lianjun Xu, Jian Tian, Xueyan Zhao, Dong Wang, Yin Zhang, Kai Sun, Channa Zhang, Bo Xu, Wei Zhao, Rutai Hui, Runlin Gao, Jizheng Wang, Xinxing Feng…
    Citation: Cardiovascular Diabetology 2023 22:333
  50. Authors: Kamel Mohammedi, Audrey Cordon, Vincent Rigalleau, Ninon Foussard, Céline Bairras-Martin, Thierry Couffinhal, Julien Bezin and Antoine Benard
    Citation: Cardiovascular Diabetology 2023 22:329

Cardiovascular Diabetology is affiliated with Sackler Faculty of Medicine, Tel-Aviv University

New Content Item

Annual Journal Metrics

  • 2022 Citation Impact
    9.3 - 2-year Impact Factor
    9.6 - 5-year Impact Factor
    2.054 - SNIP (Source Normalized Impact per Paper)
    2.361 - SJR (SCImago Journal Rank)

    2023 Speed
    4 days submission to first editorial decision for all manuscripts (Median)
    56 days submission to accept (Median)

    2023 Usage 
    2,523,778 downloads
    3,115 Altmetric mentions